SL Science Holding SLBT
NASDAQ SLBT
$1.18 -0.04 (-3.39%)
As of: Nov 4, 2026 · 3:18 PM EST

SL Science Holding (SLBT) Accumulated Expenses (2024 - 2026)

Updated

SL Science Holding's Accumulated Expenses was $202,850 in Q2 2026.

Analysis

SL Science Holding (SLBT) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at SL Science Holding came in at $319,872, up 362.3% from FY2024.

  • In earlier years, Accumulated Expenses was $69,198 in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Accumulated Expenses since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,265.73 Bn 1,239.34 Bn 20.46 Bn
2 Johnson & Johnson 666.89 Bn 586.75 Bn 17.30 Bn
3 AbbVie 516.88 Bn 484.88 Bn 13.12 Bn
4 Merck 368.47 Bn 322.85 Bn 12.21 Bn
5 Novartis Ag 319.33 Bn 292.57 Bn -
6 Astrazeneca 293.55 Bn 267.44 Bn 13.26 Bn
7 Amgen 259.05 Bn 214.45 Bn 7.24 Bn
8 Gilead Sciences 217.09 Bn 192.20 Bn 6.73 Bn
9 Pfizer 175.02 Bn 121.66 Bn 10.94 Bn
10 SL Science Holding 2.55 Bn 2.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 202,850.00
Dec 31, 2025 319,872.00
Dec 31, 2024 69,198.00
API Access

SL Science Holding Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SLBT&period=max&api_key=YOUR_API_KEY